PMC:7534795 / 48162-48380 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T362","span":{"begin":74,"end":82},"obj":"Disease"}],"attributes":[{"id":"A362","pred":"mondo_id","subj":"T362","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ndomized controlled, open-label trial in hospitalized adult patients with COVID-19 and concluded that no benefit was observed with lopinavir–ritonavir treatment beyond standard care. Moreover, about 14% of lopinavir–ri"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T295","span":{"begin":26,"end":31},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":"ndomized controlled, open-label trial in hospitalized adult patients with COVID-19 and concluded that no benefit was observed with lopinavir–ritonavir treatment beyond standard care. Moreover, about 14% of lopinavir–ri"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T33412","span":{"begin":26,"end":31},"obj":"Chemical"},{"id":"T81685","span":{"begin":131,"end":140},"obj":"Chemical"},{"id":"T64788","span":{"begin":141,"end":150},"obj":"Chemical"},{"id":"T18","span":{"begin":206,"end":215},"obj":"Chemical"}],"attributes":[{"id":"A51979","pred":"chebi_id","subj":"T33412","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"},{"id":"A54838","pred":"chebi_id","subj":"T81685","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A38640","pred":"chebi_id","subj":"T64788","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A27338","pred":"chebi_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"}],"text":"ndomized controlled, open-label trial in hospitalized adult patients with COVID-19 and concluded that no benefit was observed with lopinavir–ritonavir treatment beyond standard care. Moreover, about 14% of lopinavir–ri"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1475","span":{"begin":60,"end":68},"obj":"Species"},{"id":"1481","span":{"begin":131,"end":150},"obj":"Chemical"},{"id":"1497","span":{"begin":74,"end":82},"obj":"Disease"}],"attributes":[{"id":"A1475","pred":"tao:has_database_id","subj":"1475","obj":"Tax:9606"},{"id":"A1481","pred":"tao:has_database_id","subj":"1481","obj":"MESH:C558899"},{"id":"A1497","pred":"tao:has_database_id","subj":"1497","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ndomized controlled, open-label trial in hospitalized adult patients with COVID-19 and concluded that no benefit was observed with lopinavir–ritonavir treatment beyond standard care. Moreover, about 14% of lopinavir–ri"}